Table 3

 Association between prostate cancer and the Ephb2 K1019X polymorphism

PopulationnNo. (%) of subjects withOR (95% CI)*p
K/KK/XX/X
*OR by logistic regression for K/X and X/X genotype comparisons with AA controls after adjusting for age at diagnosis.
All cases255234 (91.7)19 (7.5)2 (0.7)2.44 (1.4 to 4.3)0.003
AA HPC7261 (84.7)11 (15.3)3.31 (1.5 to 7.4)0.008
AA sporadic PC183173 (94.5)8 (4.4)2 (1.1)1.28 (0.6 to 2.8)0.55
AA controls329312 (94.8)9 (3.2)8 (1.9)1.00 (reference)
Coriell controls231270 (98.5)4 (1.5)